12-79689914-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002583.4(PAWR):c.331G>A(p.Glu111Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000487 in 1,438,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002583.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAWR | NM_002583.4 | c.331G>A | p.Glu111Lys | missense_variant | 2/7 | ENST00000328827.9 | NP_002574.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAWR | ENST00000328827.9 | c.331G>A | p.Glu111Lys | missense_variant | 2/7 | 1 | NM_002583.4 | ENSP00000328088 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151938Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000483 AC: 2AN: 41388Hom.: 0 AF XY: 0.0000433 AC XY: 1AN XY: 23086
GnomAD4 exome AF: 0.00000389 AC: 5AN: 1286578Hom.: 0 Cov.: 32 AF XY: 0.00000318 AC XY: 2AN XY: 628560
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.331G>A (p.E111K) alteration is located in exon 2 (coding exon 1) of the PAWR gene. This alteration results from a G to A substitution at nucleotide position 331, causing the glutamic acid (E) at amino acid position 111 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at